HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are women living with HIV (the trial aims to enroll 90 women, roughly 30 in each stage of menopause)
- People who are participants at the San Francisco MWCCS site
- People who are not currently pregnant
Who may not be able to join:
- Women whose HIV is not well controlled (specifically, those with a viral load above 200 copies/mL in their blood)
- Women who are not currently taking antiretroviral therapy (HIV medication)
- Women who have had their uterus or ovaries surgically removed
- Women who are currently receiving treatment for active cancer or tuberculosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rebecca Abelman, MD, University of California, San Francisco
Phone: 415-221-4810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Markers of immune activation and inflammation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.